We are live on
!
Find out more
BFO
Boston Family Office Portfolio holdings
AUM
$1.65B
1-Year Est. Return
18.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.58%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$805M
AUM Growth
+$2.82M
(+0.35%)
Cap. Flow
-$5.52M
Cap. Flow
% of AUM
-0.69%
Top 10 Holdings %
Top 10 Hldgs %
21.48%
Holding
266
New
7
Increased
69
Reduced
92
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.49M |
| 2 |
JAH
JARDEN CORPORATION
JAH
|
+$861K |
| 3 |
AGN
Allergan plc
AGN
|
+$842K |
| 4 |
Labcorp
LH
|
+$776K |
| 5 |
Ecolab
ECL
|
+$712K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.98M |
| 2 |
AGN
Allergan Inc
AGN
|
+$1.74M |
| 3 |
Gilead Sciences
GILD
|
+$1.33M |
| 4 |
TFM
THE FRESH MARKET, INC COM STK
TFM
|
+$1.26M |
| 5 |
CELG
Celgene Corp
CELG
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.07% |
| 2 | Industrials | 14.98% |
| 3 | Miscellaneous | 14.57% |
| 4 | Technology | 12.91% |
| 5 | Consumer Staples | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
ICICI Bank
IBN
$102B
| $207K | 0.03% |
22,000
| – | – |
|
252
iShares Expanded Tech Sector ETF
IGM
$10.5B
| $206K | 0.03% |
12,000
| – | – |
|
|
LLTC
253
DELISTED
Linear Technology Corp
LLTC
| $204K | 0.03% |
+4,365
| New | +$204K |
|
254
Chubb
CB
$132B
| $200K | 0.02% |
1,795
| – | – |
|
|
HAPN
255
Happen Inc
HAPN
$1.88B
| $196K | 0.02% |
+2,000
| New | +$208K |
|
256
Bank of America
BAC
$417B
| – | – |
-12,268
| Closed | -$219K |
|
257
Fastenal
FAST
$56.7B
| – | – |
-20,360
| Closed | -$242K |
|
|
MDRX
258
DELISTED
Veradigm Inc. Common Stock
MDRX
| – | – |
-17,200
| Closed | -$220K |
|
|
GNC
259
DELISTED
GNC Holdings, Inc.
GNC
| – | – |
-10,785
| Closed | -$506K |
|
|
TFM
260
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| – | – |
-30,700
| Closed | -$1.26M |
|
|
COV
261
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| – | – |
-19,355
| Closed | -$1.98M |
|
|
AGN
262
DELISTED
Allergan Inc
AGN
| – | – |
-8,183
| Closed | -$1.74M |
|
Similar funds
MCIL
BCM
SOS
GS
NPA
AAM
OHIF
SCM
Boston Family Office's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Family Office held 266 positions worth $805M, up 0.35% from $803M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Boston Family Office's Q1 2015 filing shows 7 new, 69 increased, 92 reduced and 7 closed positions. Its largest new stake was Medtronic: 19,713 shares worth $1.54M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $1.98M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Miscellaneous.
- Boston Family Office's largest Q1 2015 buy was Medtronic: 19,713 shares worth $1.54M.
- Boston Family Office added most to Allergan plc in Q1 2015, an estimated $842K increase.
- Boston Family Office's biggest Q1 2015 reduction was Gilead Sciences, cutting an estimated $1.33M.
- Boston Family Office fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $1.98M.
- Boston Family Office's ten largest holdings make up 21% of its $805M portfolio in Q1 2015.
- Boston Family Office opened 7 new positions and closed 7 in Q1 2015.
- Boston Family Office's portfolio value rose 0.35% quarter-over-quarter to $805M.
Based on Boston Family Office's 13F filing for Q1 2015, filed 11 May 2015.